Objective: To summarize evidence on the rates and drivers of progression from
normoglycemia to prediabetes and/or diabetes mellitus (hereafter “diabetes”) in antiretroviral …

Summary Background Non-communicable diseases (NCDs) are increasing among people
living with HIV (PLHIV), especially in Sub-Saharan Africa (SSA). We determined the …

Background Recent studies have reported weight gain in virologically suppressed persons
living with human immunodeficiency virus (PLWH) switched from older antiretroviral therapy …

Introduction Antiretroviral therapy (ART) has changed the course of HIV/AIDs by enabling
patients to live longer, raising concern of the co-existence of HIV with other chronic illnesses …

Objective This study evaluated body mass index (BMI) and weight changes in people living
with human immunodeficiency virus (HIV-1; PLWH) initiated on single-tablet …

Background India has a high prevalence of tuberculosis (TB) as well as diabetes mellitus
(DM). DM is a chronic disease caused by deficiency of insulin production by the pancreas …

Objectives HIV infection environment presents a classic example of the interplay between
infectious diseases and non-communicable diseases (NCDs). Traditional cardiovascular …

Objective. To review available literature on the prevalence, risk factors, pathophysiology,
and clinical outcomes of dysglycemia among people living with HIV (PLHIV) in sub‐Saharan …

Background. As of April 2019, the dolutegravir (DTG)‐based regimen is replacing the
efavirenz‐based regimen in Ethiopia, mainly due to its superiority in viral load suppression …

Introduction In people living with human immunodeficiency virus (PLHIV), traditional
cardiovascular risk factors, exposure to HIV per se and antiretroviral therapy (ART) are …